Advertisement
Research Article| Volume 123, ISSUE 8, P1277-1282, April 15, 2019

Download started.

Ok

Occurrence of Atrial Fibrillation During Dobutamine Stress Echocardiography

  • Nicolas Mansencal
    Correspondence
    Corresponding author: Tel: +33 (0)149095619; fax: +33 (0)149095344.
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
  • Hazrije Mustafic
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
  • Marie Hauguel-Moreau
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
  • Simon Lannou
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
  • Catherine Szymanski
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
  • Olivier Dubourg
    Affiliations
    Department of Cardiology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, Université de Versailles-Saint Quentin (UVSQ), Boulogne, France

    INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France
    Search for articles by this author
Published:January 31, 2019DOI:https://doi.org/10.1016/j.amjcard.2019.01.022
      Dobutamine stress echocardiography (DSE) is a widely used examination for assessment of coronary ischemia, but several complications have been reported. The aim of this study was to assess the incidence of atrial fibrillation (AF) during DSE, and a systematic review and meta-analysis were also performed to determine an accurate estimate of the AF incidence. Over a 16-year period, we reviewed all patients referred for DSE. We systematically analyzed all ECG performed during DSE to detect AF during the examination. DSE was completely performed in 4,818 patients (mean age: 62.1 ± 11.7 years). AF was observed in 40 patients (31 men, mean age: 79.7 ± 8.9 years). Incidence of AF during DSE was 0.83%. Regarding the meta-analysis, the combined AF incidence was 0.86%. In our study, patients with AF occurrence had more frequent previous history of paroxysmal AF (p = 0.02) were also older (p < 0.0001) and incidence of AF during DSE increased with age: 0% below 60 years, 0.45% in patients 60 to 69 years, 1.3% in patients 70 to 79 years, and 4% in patients >80 years (p < 0.0001). In multivariate analysis, the factors significantly associated with an increased risk of AF were age (adjusted odds ratio (aOR) = 2.4, 95% confidence interval: 1.5 to 3.3, p = 0.003) and previous history of paroxysmal AF (aOR = 1.5, 95% confidence interval: 1.1 to 1.9; p = 0.04). In conclusion, AF is uncommon during DSE, and elderly patients and patients with previous history of paroxysmal AF are at risk of AF during DSE.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Geleijnse M.L.
        • Krenning B.J.
        • Nemes A.
        • van Dalen B.M.
        • Soliman O.I.
        • Ten Cate F.J.
        • Schinkel A.F.
        • Boersma E.
        • Simoons M.L.
        Incidence, pathophysiology, and treatment of complications during dobutamine–atropine stress echocardiography.
        Circulation. 2010; 121: 1756-1767
        • Mansencal N.
        • El Hajjaji I.
        • El Mahmoud I.
        • Digne F.
        • Dubourg O.
        Prevalence of coronary artery spasm during dobutamine stress echocardiography.
        Am J Cardiol. 2012; 109: 800-804
        • Mertes H.
        • Sawada S.G.
        • Ryan T.
        • Segar D.S.
        • Kovacs R.
        • Foltz J.
        • Feigenbaum H.
        Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1118 patients.
        Circulation. 1993; 88: 15-19
        • Poldermans D.
        • Fioretti P.M.
        • Boersma E.
        • Forster T.
        • van Urk H.
        • Cornel J.H.
        • Arnese M.
        • Roelandt R.T.
        Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.
        Am J Cardiol. 1994; 73: 456-459
        • Fetiveau R.
        • Lanzarini L.
        • Poli A.
        • Diotallevi P.
        • Mussini M.F.
        • Montemartini C.
        • Previtali M.
        The side effects and safety of the echo-dobutamine test. The experience with 373 patients [in Italian].
        G Ital Cardiol. 1995; 25: 193-201
        • Cornel J.H.
        • Balk A.H.
        • Boersma E.
        • Maat A.P.
        • Elhendy A.
        • Arnese M.
        • Salustri A.
        • Roelandt J.R.
        • Fioretti P.M.
        Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction.
        J Am Soc Echocardiogr. 1996; 9: 27-32
        • Zahn R.
        • Lotter R.
        • Nohl H.
        • Schiele R.
        • Bergmeier C.
        • Zander M.
        • Seidl K.
        • Senges J.
        Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies [in German].
        Z Kardiol. 1996; 85: 28-34
        • Yeo T.C.
        • Ng W.L.
        • Ling L.H.
        • Chai P.
        • Yeoh J.K.
        • Choo M.H.
        Dobutamine stress echocardiography in the elderly Asian patients.
        Ann Acad Med Singapore. 1997; 26: 165-167
        • Secknus M.A.
        • Marwick T.H.
        Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years.
        J Am Coll Cardiol. 1997; 29: 1234-1240
        • Pinton R.
        • Lemke W.
        • Garcia L.G.
        Symptoms, complications and hemodynamic changes related to dobutamine stress echocardiography [in Portuguese].
        Arq Bras Cardiol. 1997; 69: 161-164
        • Lamisse N.
        • Cohen A.
        • Chauvel C.
        • Benhalima B.
        • Désert I.
        • Buyukoglu B.
        • Blanchard B.
        • Albo C.
        • Boccara F.
        • Valty J.
        Dobutamine stress echocardiography: a monocentric experience on 600 consecutive patients: effect of age [in French].
        Arch Mal Coeur Vaiss. 1997; 90: 1455-1461
        • Hennessy T.G.
        • Codd M.B.
        • Kane G.
        • McCarthy C.
        • McCann H.A.
        • Sugrue D.D.
        Safety of dobutamine stress echocardiography in 474 consecutive studies.
        Coron Artery Dis. 1997; 8: 175-178
        • Bremer M.L.
        • Monahan K.H.
        • Stussy V.L.
        • Miller Jr, F.A.
        • Seward J.B.
        • Pellikka P.A.
        Safety of dobutamine stress echocardiography supervised by registered nurse sonographers.
        J Am Soc Echocardiogr. 1998; 11: 601-605
        • Pezzano A.
        • Gentile F.
        • Mantero A.
        • Morabito A.
        • Ravizza P.
        RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations.
        G Ital Cardiol. 1998; 28: 102-111
        • Elhendy A.
        • van Domburg R.T.
        • Bax J.J.
        • Roelandt J.R.
        Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography.
        Am J Cardiol. 1999; 83: 832-835
        • Mathias Jr, W.
        • Arruda A.
        • Santos F.C.
        • Arruda A.L.
        • Mattos E.
        • Osório A.
        • Campos O.
        • Gil M.
        • Andrade J.L.
        • Carvalho A.C.
        Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies.
        J Am Soc Echocardiogr. 1999; 12: 785-791
        • Płońska E.
        • Szwed H.
        • Gasior Z.
        • Drozdz J.
        • Gackowski A.
        • Szyszka A.
        • Sieńko A.
        • Flasiński J.
        • Swiatkiewicz I.
        • Sas M.
        • Demczuk M.
        • Kleinrok A.
        • Krzymińska E.
        Side effects during dobutamine stress echocardiography: analysis of 582 studies [in Polish].
        Pol Merkuriusz Lek. 1999; 7: 164-168
        • Takeuchi M.
        • Miura Y.
        • Sonoda S.
        • Kuroiwa A.
        Comparison of three different protocols for dobutamine stress echocardiography: does the addition of atropine increase complications, and does it improve diagnostic accuracy?.
        Echocardiography. 1999; 16: 347-355
        • Chenzbraun A.
        • Khoury Z.
        • Gottlieb S.
        • Keren A.
        Impact of age on the safety and the hemodynamic response pattern during high dose dobutamine echocardiography.
        Echocardiography. 1999; 16: 135-142
        • Coisne D.
        • Donal E.
        • Torremocha F.
        • Christiaens L.
        • Allal J.
        Dobutamine stress echocardiography response of asymptomatic patients with diabetes.
        Echocardiography. 2001; 18: 373-379
        • Cortigiani L.
        • Picano E.
        • Coletta C.
        • Chiarella F.
        • Mathias W.
        • Gandolfo N.
        • De Alcantara M.
        • Mazzoni V.
        • Gensini G.F.
        • Landi P.
        • Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group
        Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.
        Am Heart J. 2001; 141: 621-629
        • Tsutsui J.M.
        • Osório A.F.
        • Lario F.A.
        • Fernandes D.R.
        • Sodre G.
        • Andrade J.L.
        • Ramires J.A.
        • Mathias Jr, W.
        Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol.
        Am J Cardiol. 2004; 94: 1367-1372
        • Carasso S.
        • Sandach A.
        • Kuperstein R.
        • Schwammenthal E.
        • Glikson M.
        • Luria D.
        • Guetta V.
        • Shechter M.
        • Eldar M.
        • Feinberg M.S.
        Atrial fibrillation in dobutamine stress echocardiography.
        Int J Cardiol. 2006; 111: 53-58
        • Wejner-Mik P.
        • Drozdz J.
        • Lipiec P.
        • Krzemińska-Pakuła M.
        • Ciesielczyk M.
        • Kasprzak J.D.
        Prevalence of dangerous arrhythmia during pharmacological stress echocardiography [in Polish].
        Pol Merkur Lekarski. 2006; 20: 635-638
        • San Román J.A.
        • Sanz-Ruiz R.
        • Ortega J.R.
        • Pérez-Paredes M.
        • Rollán M.J.
        • Muñoz A.C.
        • Segura F.
        • Jimenez D.
        • Carnero A.
        • Pinedo M.
        • Arnold R.
        • Gómez I.
        • Fernández-Aviles F.
        Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol.
        J Am Soc Echocardiogr. 2008; 21: 53-57
        • Mikheev N.N.
        Complications of stress-echocardiography used for diagnosis of ischemic heart disease [Russian].
        Kardiologiia. 2008; 48: 19-23
        • Aggeli C.
        • Giannopoulos G.
        • Roussakis G.
        • Christoforatou E.
        • Marinos G.
        • Toli C.
        • Pitsavos C.
        • Stefanadis
        Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies.
        Heart. 2008; 94: 1571-1577
        • Abdel-Salam Z.
        • Nammas W.
        Early atropine is safer than conventional atropine administration in the elderly undergoing dobutamine stress echocardiography.
        Kardiol Pol. 2010; 68: 422-428
        • Sheldon S.H.
        • Askew 3rd, J.W.
        • Klarich K.W.
        • Scott C.G.
        • Pellikka P.A.
        • McCully R.B.
        Occurrence of atrial fibrillation during dobutamine stress echocardiography: incidence, risk factors, and outcomes.
        J Am Soc Echocardiogr. 2011; 24: 86-90
        • Acharya Y.
        • Agrawal S.
        • Bhattarai J.
        • Cotarlan V.
        • Shirani J.
        Predictors and prognostic significance of atrial fibrillation developed during dobutamine stress echocardiography: A propensity score-matched comparison.
        Echocardiography. 2017; 34: 429-435